Skip to main content

Table 4 CGI-SI scale at baseline and 24w

From: Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism

Scale

Baseline

24w

Combination

CBMNC

Control

*Combinationab

*CBMNCa

Control

0 - n(%)

0(0.00%)

0(0.00%)

0(0.00%)

0(0.00%)

0(0.00%)

1(7.69%)

1 - n(%)

0(0.00%)

0(0.00%)

0(0.00%)

1(11.11%)

0(0.00%)

0(0.00%)

2 - n(%)

0(0.00%)

0(0.00%)

0(0.00%)

0(0.00%)

1(7.14%)

0(0.00%)

3 - n(%)

2(22.22%)

1(7.14%)

1(7.14%)

5(55.56%)

4(28.57%)

0(0.00%)

4 - n(%)

2(22.22%)

5(35.71%)

7(50.00%)

3(33.33%)

4(28.57%)

12(92.31%)

5 - n(%)

2(22.22%)

1(7.14%)

3(21.43%)

0(0.00%)

2(14.29%)

0(0.00%)

6 - n(%)

3(33.33%)

6(42.86%)

3(21.43%)

0(0.00%)

2(14.29%)

1(7.69%)

7 - n(%)

0(0.00%)

1(7.14%)

0(0.00%)

0(0.00%)

1(7.14%)

0(0.00%)

Total (missed)

9(0)

14(0)

14(0)

9(0)

14(0)

13(1)

  1. Note: 0 = Not assessed; 1 = Normal, not at all ill; 2 = Borderline mentally ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; 7 = Among the most extremely ill patients. *The frequency of participants who scored “Mildly ill” or better was significantly increased at 24w when compared to baseline (p < 0.05). aThe frequency of participants who scored “Mildly ill” or better in the Combination or CBMNC group was significantly increased when compared with the Control group at 24w (p < 0.05). bThe frequency of participants who scored “Mildly ill” or better in the Combination group was significantly increased when compared with the CBMNC group at 24w (p < 0.05).